(Q40785380)

23 September 2017

1 reference

title

Autoimmunity in schizophrenia: a review of recent findings (English)

1 reference

23 September 2017

0 references

Ganguli R

1

1 reference

23 September 2017

Brar JS

2

1 reference

23 September 2017

Chengappa KN

3

1 reference

23 September 2017

Yang ZW

4

1 reference

23 September 2017

Nimgaonkar VL

5

1 reference

23 September 2017

Rabin BS

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 October 1993

1 reference

23 September 2017

1 reference

23 September 2017

volume

25

1 reference

23 September 2017

issue

5

1 reference

23 September 2017

page(s)

489-496

1 reference

Physical Illness Presenting as Psychiatric Disease

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Schizophrenia as an immunologic disorder. II. Effects of serum protein fractions on brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Clinical and laboratory evidence of autoimmunity in acute schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Immunologic and Coagulation Disorders in Chlorpromazine-Treated Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Can autoimmune mechanisms account for the genetic predisposition to schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Pathogenic mechanisms in autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Increased numbers of CD5+ B lymphocytes in schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

The role of interleukin 2 in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Antibody to discrete areas of the brain in normal individuals and patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Temporal lobe asymmetries as the key to the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Brain neocortex modulation of mitogen-induced interleukin 2, but not interleukin 1, production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Towards an aetiological classification of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

Should be biologic marker be sensitive and specific?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147317

10.3109/07853899309147317

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference